https://www.medicannacr.com/es/researches-2/cannabinoids-in-multiple-sclerosis-(cams)-study%3A-safety-and-efficacy-data-for-12-months-follow-up 2023-11-18 https://www.medicannacr.com/es/researches-2/adverse-effects-of-medical-cannabinoids%3A-a-systematic-review 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabinoids-and-glaucoma 2023-11-18 https://www.medicannacr.com/es/researches-2/association-between-marijuana-exposure-and-pulmonary-function-over-20-years 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabis-and-cannabinoids-(pdq%C2%AE)%E2%80%93health-professional-version 2023-11-18 https://www.medicannacr.com/es/researches-2/multicenter%2C-double-blind%2C-randomized%2C-placebo-controlled%2C-parallel-group-study-of-the-efficacy%2C-safety%2C-and-tolerability-of-thc%3Acbd-extract-and-thc-extract-in-patients-with-intractable-cancer-related-pain 2023-11-18 https://www.medicannacr.com/es/researches-2/dronabinol-and-marijuana-in-hiv-positive-marijuana-smokers-caloric-intake%2C-mood%2C-and-sleep 2023-11-18 https://www.medicannacr.com/es/researches-2/a-pilot-clinical-study-of-d9--tetrahydrocannabinol-in-patients-with-recurrent-glioblastoma-multiforme 2023-11-18 https://www.medicannacr.com/es/researches-2/the-therapeutic-potential-of-cannabis-and-cannabinoids 2023-11-18 https://www.medicannacr.com/es/researches-2/smoked-medicinal-cannabis-for-neuropathic-pain-in-hiv%3A-a-randomized%2C-crossover-clinical-trial 2023-11-18 https://www.medicannacr.com/es/researches-2/the-adverse-effects-of-cannabinoids%3A-implications-for-use-of-medical-marijuana 2023-11-18 https://www.medicannacr.com/es/researches-2/smoked-cannabis-for-spasticity-in-multiple-sclerosis%3A-a-randomized%2C-placebo-controlled-trial 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabis-in-palliative-medicine%3A-improving-care-and-reducing-opioid-related-morbidity 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabis-and-amyotrophic-lateral-sclerosis%3A-hypothetical-and-practical-applications%2C-and-a-call-for-clinical-trials 2023-11-18 https://www.medicannacr.com/es/researches-2/survey-of-cannabis-use-in-patients-with-amyotrophic-lateral-sclerosis 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabis-in-painful-hiv-associated-sensory-neuropathy%3A-a-randomized-placebo-controlled-trial 2023-11-18 https://www.medicannacr.com/es/researches-2/palliative-care 2023-11-18 https://www.medicannacr.com/es/researches-2/chemotherapy-induced-nausea-and-vomiting 2023-11-18 https://www.medicannacr.com/es/researches-2/paediatric-epilepsy 2023-11-18 https://www.medicannacr.com/es/researches-2/medicinal-cannabis-in-children-and-adolescents-with-autismspectrum-disorder%3A-a-scoping-review 2023-11-18 https://www.medicannacr.com/es/researches-2/medical-cannabis-%E2%80%93-the-canadian-perspective 2023-11-18 https://www.medicannacr.com/es/researches-2/a-mapping-literature-review-of-medical-cannabis 2023-11-18 https://www.medicannacr.com/es/researches-2/therapeutic-effects-of-cannabis-and-cannabinoids 2023-11-18 https://www.medicannacr.com/es/researches-2/medical-cannabis-or-cannabinoids-for-chronic-pain%3A-a-clinical-practice-guideline 2023-11-18 https://www.medicannacr.com/es/researches-2/a-randomized-trial-of-medical-cannabis-in-patients-with-stage-iv-cancers-to-assess-feasibility%2C-dose-requirements%2C-impact-on-pain-and-opioid-use%2C-safety%2C-and-overall-patient-satisfaction-zylla-et-al.-(2021) 2023-11-18 https://www.medicannacr.com/es/researches-2/the-effectiveness-of-topical-cannabidiol-oil-in-symptomatic-relief-of-peripheral-neuropathy-of-the-lower-extremities-xu-et-al.-(2020) 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabidiol-for-the-reduction-of-cue-induced-craving-and-anxiety-in-drug-abstinent-individuals-with-heroin-use-disorder%3A-a-double-blind-randomized-placebo-controlled-trial-hurd-et-al.-(2019) 2023-11-18 https://www.medicannacr.com/es/researches-2/food-effect-on-pharmacokinetics-of-cannabidiol-oral-capsules-in-adult-patients-with-refractory-epilepsy-birnbaum-et-al.-(2019) 2023-11-18 https://www.medicannacr.com/es/researches-2/the-effect-of-cannabidiol-(cbd)-on-low-frequency-activity-and-functional-connectivity-in-the-brain-of-adults-with-and-without-autism-spectrum-disorder-(asd)-pretzsch-et-al.-(2019c) 2023-11-18 https://www.medicannacr.com/es/researches-2/effects-of-cannabidiol-on-brain-excitation-and-inhibition-systems%3B-a-randomised-placebo-controlled-single-dose-trial-during-magnetic-resonance-spectroscopy-in-adults-with-and-without-autism-spectrum-disorder-pretzsch-et-al.-(2019a) 2023-11-18 https://www.medicannacr.com/es/researches-2/normalization-of-mediotemporal-and-prefrontal-activity%2C-and-mediotemporal-striatal-connectivity%2C-may-underlie-antipsychotic-effects-of-cannabidiol-in-psychosis-o'neill-et-al.-(2021) 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabidiol-for-the-treatment-of-cannabis-use-disorder%3A-a-phase-2a%2C-double-blind%2C-placebo-controlled%2C-randomised%2C-adaptive-bayesian-trial-freeman-et-al.-(2020) 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabidiol-enhances-verbal-episodic-memory-in-healthy-young-participants%3A-a-randomized-clinical-trial-hotz-et-al.-(2021) 2023-11-18 https://www.medicannacr.com/es/researches-2/effect-of-adding-medical-cannabis-to-analgesic-treatment-in-patients-with-low-back-pain-related-to-fibromyalgia%3A-an-observational-cross-over-single-centre-study-yassin-et-al.-(2019) 2023-11-18 https://www.medicannacr.com/es/researches-2/the-safety%2C-tolerability%2C-and-effectiveness-of-ptl-101%2C-an-oral-cannabidiol-formulation%2C-in-pediatric-intractable-epilepsy%3A-a-phase-ii%2C-open-label%2C-single-center-study 2023-11-18 https://www.medicannacr.com/es/researches-2/pharmacokinetic-investigation-of-synthetic-cannabidiol-oral-formulations-in-healthy-volunteers 2023-11-18 https://www.medicannacr.com/es/researches-2/the-pharmacokinetics%2C-efficacy%2C-and-safety-of-a-novel-selective-dose-cannabis-inhaler-in-patients-with-chronic-pain%3A-a-randomized%2C-double-blinded%2C-placebo-controlled-trial 2023-11-18 https://www.medicannacr.com/es/researches-2/a-phase-1%2C-randomised%2C-placebo-controlled%2C-dose-escalation-study-to-investigate-the-safety%2C-tolerability-and-pharmacokinetics-of-cannabidiol-in-fed-healthy-volunteers 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabis-use-in-patients-3-months-after-ceasing-nabiximols-for-the-treatment-of-cannabis-dependence%3A-results-from-a-placebo-controlled-randomised-trial 2023-11-18 https://www.medicannacr.com/es/researches-2/oral-thc%3Acbd-cannabis-extract-for-refractory-chemotherapy-induced-nausea-and-vomiting%3A-a-randomised%2C-placebo-controlled%2C-phase-ii-crossover-trial 2023-11-18 https://www.medicannacr.com/es/researches-2/a-pilot-randomised-placebo-controlled-trial-of-cannabidiol-to-reduce-severe-behavioural-problems-in-children-and-adolescents-with-intellectual-disability 2023-11-18 https://www.medicannacr.com/es/researches-2/cannabis-for-medical-use%3A-analysis-of-recent-clinical-trials-in-view-of-current-legislation 2023-11-18